Antiplatelet and Anticoagulation Therapy in Structural Heart Disease Interventions Beyond TAVI

被引：2
作者：
Vavuranakis, Manolis [1 ,2 ]
Boudoulas, Konstantinos D. [2 ]
Katsarou, Ourania [1 ]
Vrachatis, Dimitrios A. [1 ]
Kalogeras, Konstantinos I. [1 ]
Papaioannou, Theodore G. [1 ]
Siasos, Gerasimos [1 ]
Oikonomou, Evangelos [1 ]
Lazaros, George [1 ]
Vavuranakis, Michael-Andreas [1 ]
Deftereos, Spyridon [3 ,4 ]
Tousoulis, Dimitrios [1 ]
机构：
[1] Natl & Kapodistrian Univ Athens, Hippokrat Hosp, Dept Cardiol 1, Athens, Greece
[2] Ohio State Univ, Dept Cardiovasc Med, Columbus, OH 43210 USA
[3] Natl & Kapodistrian Univ Athens, Attikon Hosp, Dept Cardiol 2, Athens, Greece
[4] Yale Univ, Sch Med, Sect Cardiovasc Med, New Haven, CT 06520 USA
来源：
CURRENT PHARMACEUTICAL DESIGN | 2017年 / 23卷 / 09期
关键词：
ASD; LAA; PFO; transcatheter; warfarin; coumadin; antiplatelet; NOAC; LEFT ATRIAL APPENDAGE; PATENT FORAMEN OVALE; TRANSCATHETER OCCLUSION PLAATO; TRANSIENT ISCHEMIC ATTACK; 2010 ESC GUIDELINES; HIGH-RISK PATIENTS; PERCUTANEOUS CLOSURE; STROKE PREVENTION; PARADOXICAL EMBOLISM; ORAL ANTICOAGULANTS;
D O I：
10.2174/1381612822666161221143416
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Transcatheter interventions for structural heart disease represent an emerging field in interventional cardiology. Undoubtedly, there is an absolute necessity for antiplatelet and/or anticoagulation treatment prior, during and post such interventions. However, currently administered regimens are mainly based in expert consensus recommendations. In the present review we aim to summarize data regarding anti platelet and/or anticoagulation treatment in the following transcatheter structural heart interventions: left atrial appendage closure, atrial septal defect closure, patent foramen oval closure, paravalvular leak closure.
引用
收藏
页码：1328 / 1333
页数：6
相关论文
共 90 条
  • [11] Percutaneous Mitral and Aortic Paravalvular Leak Repair: Indications, Current Application, and Future Directions
    Binder, Ronald K.
    Webb, John G.
    [J]. CURRENT CARDIOLOGY REPORTS, 2013, 15 (03)
  • [12] Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation
    Blackshear, JL
    Odell, JA
    [J]. ANNALS OF THORACIC SURGERY, 1996, 61 (02) : 755 - 759
  • [13] Percutaneous Left Atrial Appendage Occlusion for Patients in Atrial Fibrillation Suboptimal for Warfarin Therapy 5-Year Results of the PLAATO (Percutaneous Left Atrial Appendage Transcatheter Occlusion) Study
    Block, Peter C.
    Burstein, Steven
    Casale, Paul N.
    Kramer, Paul H.
    Teirstein, Paul
    Williams, David O.
    Reisman, Mark
    [J]. JACC-CARDIOVASCULAR INTERVENTIONS, 2009, 2 (07) : 594 - 600
  • [14] Fibrosis in left atrial tissue of patients with atrial fibrillation with and without underlying mitral valve disease
    Boldt, A
    Wetzel, U
    Lauschke, J
    Weigl, J
    Gummert, J
    Hindricks, G
    Kottkamp, H
    Dhein, S
    [J]. HEART, 2004, 90 (04) : 400 - 405
  • [15] Boudoulas KD, 2001, ARCH PATHOL LAB MED, V125, P112
  • [16] Estradiol increases platelet aggregation in PlA1/A1 individuals
    Boudoulas, Konstantinos D.
    Montague, Christine Roos
    Goldschmidt-Clermont, Pascal J.
    Cooke, Glen E.
    [J]. AMERICAN HEART JOURNAL, 2006, 152 (01) : 136 - 139
  • [17] Transcatheter closure of patent foramen ovale (PFO) in patients with paradoxical embolism - Periprocedural safety and mid-term follow-up results of three different device occluder systems
    Braun, M
    Gliech, V
    Boscheri, A
    Schoen, S
    Gahn, G
    Reichmann, H
    Haass, M
    Schraeder, R
    Strasser, RH
    [J]. EUROPEAN HEART JOURNAL, 2004, 25 (05) : 424 - 430
  • [18] Transcatheter closure of patent foramen ovale in patients with cerebral ischemia
    Braun, MU
    Fassbender, D
    Schoen, SP
    Haass, M
    Schraeder, R
    Scholtz, W
    Strasser, RH
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2002, 39 (12) : 2019 - 2025
  • [19] TRANSCATHETER CLOSURE OF PATENT FORAMEN OVALE AFTER PRESUMED PARADOXICAL EMBOLISM
    BRIDGES, ND
    HELLENBRAND, W
    LATSON, L
    FILIANO, J
    NEWBURGER, JW
    LOCK, JE
    [J]. CIRCULATION, 1992, 86 (06) : 1902 - 1908
  • [20] Why do patients with atrial fibrillation not receive warfarin?
    Bungard, TJ
    Ghali, WA
    Teo, KK
    McAlister, FA
    Tsuyuki, RT
    [J]. ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (01) : 41 - 46
123456789